GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alzinova AB (OSTO:ALZ) » Definitions » Enterprise Value

Alzinova AB (OSTO:ALZ) Enterprise Value : kr290.85 Mil (As of Dec. 13, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Alzinova AB Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Alzinova AB's Enterprise Value is kr290.85 Mil. Alzinova AB's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 was kr-18.47 Mil. Therefore, Alzinova AB's EV-to-EBIT ratio for today is -15.75.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Alzinova AB's Enterprise Value is kr290.85 Mil. Alzinova AB's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 was kr-18.47 Mil. Therefore, Alzinova AB's EV-to-EBITDA ratio for today is -15.75.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Alzinova AB's Enterprise Value is kr290.85 Mil. Alzinova AB's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 was kr0.30 Mil. Therefore, Alzinova AB's EV-to-Revenue ratio for today is 969.51.


Alzinova AB Enterprise Value Historical Data

The historical data trend for Alzinova AB's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alzinova AB Enterprise Value Chart

Alzinova AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial 70.12 66.30 73.56 58.56 113.93

Alzinova AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 94.01 113.93 69.20 61.54 293.32

Competitive Comparison of Alzinova AB's Enterprise Value

For the Biotechnology subindustry, Alzinova AB's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alzinova AB's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alzinova AB's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Alzinova AB's Enterprise Value falls into.



Alzinova AB Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Alzinova AB's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Alzinova AB's Enterprise Value for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alzinova AB  (OSTO:ALZ) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Alzinova AB's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=290.853/-18.472
=-15.75

Alzinova AB's current Enterprise Value is kr290.85 Mil.
Alzinova AB's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-18.47 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Alzinova AB's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=290.853/-18.472
=-15.75

Alzinova AB's current Enterprise Value is kr290.85 Mil.
Alzinova AB's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-18.47 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Alzinova AB's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=290.853/0.3
=969.51

Alzinova AB's current Enterprise Value is kr290.85 Mil.
Alzinova AB's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alzinova AB Enterprise Value Related Terms

Thank you for viewing the detailed overview of Alzinova AB's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Alzinova AB Business Description

Traded in Other Exchanges
Address
Pepparedsleden 1, Molndal, SWE, SE-431 83
Alzinova AB is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company is engaged in the development of a specific oligomer-directed vaccine (ALZ-101), and ALZ-201 which is a monoclonal antibody that is specific for the toxic AB oligomers. The products of the company are in the clinical and preclinical stages of development as a therapeutic vaccine for the treatment of Alzheimer's.

Alzinova AB Headlines

No Headlines